Most cited article - PubMed ID 2844587
Processed enzymatically active protease (p15gag) of avian retrovirus obtained in an E. coli system expressing a recombinant precursor (Pr25lac-delta gag)
In an attempt to understand the structural reasons for differences in specificity and activity of proteinases from two retroviruses encoded by human immunodeficiency virus (HIV) and myeloblastosis associated virus (MAV), we mutated five key residues predicted to form part of the enzyme subsites S1, S2 and S3 in the substrate binding cleft of the wild-type MAV proteinase wMAV PR. These were changed to the residues occupying a similar or identical position in the HIV-1 enzyme. The resultant mutated MAV proteinase (mMAV PR) exhibits increased enzymatic activity, altered substrate specificity, a substantially changed pH activity profile and a higher pH stability close to that observed in the HIV-1 PR. This dramatic alteration of MAV PR activity achieved by site-directed mutagenesis suggests that we have identified the amino acid residues contributing substantially to the differences between MAV and HIV-1 proteinases.
- MeSH
- Endopeptidases genetics metabolism MeSH
- HIV Protease genetics metabolism MeSH
- Kinetics MeSH
- Hydrogen-Ion Concentration MeSH
- Protein Conformation MeSH
- Molecular Sequence Data MeSH
- Mutagenesis, Site-Directed MeSH
- Protein Engineering MeSH
- Retroviridae enzymology MeSH
- Amino Acid Sequence MeSH
- Substrate Specificity MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Endopeptidases MeSH
- HIV Protease MeSH